BioDuro and AstraZeneca Expand Collaboration to Optimize Discovery Research for Respiratory and Inflammation Indications
Posted on: Monday, 23 March 2009, 08:00 CDT
BioDuro will provide integrated research services in the areas of discovery chemistry, discovery biology, ADMET*, and DMPK** services, to help enhance internal drug discovery and shorten development timelines.
"After a successful collaboration involving discovery chemistry, ADMET, and DMPK, AstraZeneca has expanded its collaboration with BioDuro to leverage the strengths of its team to help develop new therapeutics," said Lena Martensson Director of Strategic Planning and Business Development.
"BioDuro is pleased to build upon this existing collaboration and work closely with the experienced team at AstraZeneca to develop new clinical compounds for Respiratory and Inflammation indications. This partnership demonstrates the strength of our innovation, quality, and our fully integrated R&D service platform," commented
About AstraZeneca
AstraZeneca is a major international healthcare business engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of
About BioDuro
BioDuro is a US-based, fully-integrated, end-to-end global life science outsourcing services company with a team of 580 in
*ADMET: Absorption, Distribution, Metabolism, Excretion, and Toxicity
**DMPK: Drug Metabolism and Pharmacokinetics
SOURCE BioDuro, LLC
Source: PR Newswire
Related Articles
- Project To Coordinate Antimalarial Drug Research
- NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
- Ardea Biosciences, Inc. Announces Appointment of Patrick M. O'Connor As Senior Vice President of Research and Preclinical Development and Chief Scientific Officer
- AstraZeneca Brain Tumor Drug Shows Promise
- Taiwanese Researchers Work to Develop Anti-Fear Drug
- Drug-Research Firm to Open in Old Mill
- Top Drug Researcher Lands at U: Her $7.8 Million NIH Grant Will Follow Her
- AaiPharma Tries to Regain Its Footing in the Contract Drug Research Industry
- Drug Researcher MDS Adds Beds in Lincoln
 |
 |
User Comments (0)
RSS Feeds